You have 9 free searches left this month | for more free features.

etoposide

Showing 1 - 25 of 793

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Glioblastoma Multiforme Trial in Edmonton (Tamoxifen, Etoposide)

Recruiting
  • Glioblastoma Multiforme
  • Edmonton, Alberta, Canada
    Cross Cancer Institute
Mar 28, 2022

Hemophagocytic Lymphohistiocytosis Trial in Beijing (Venetoclax, Dexamethasone, Etoposide)

Recruiting
  • Hemophagocytic Lymphohistiocytosis
  • Beijing, Beijing, China
    Beijing Friendship Hospital, Capital Medical University
Sep 15, 2022

Leukemia Trial in Houston (Alemtuzumab, Etoposide, Dexamethasone)

Active, not recruiting
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Feb 2, 2022

Germ Cell Tumor, Non-seminomatous Germ Cell Tumor, Ovarian Germ Cell Tumor Trial in Indianapolis (Etoposide)

Recruiting
  • Germ Cell Tumor
  • +2 more
  • Etoposide
  • Indianapolis, Indiana
    Indiana University Melvin & Bren Simon Cancer Center
Feb 23, 2022

Brain Tumor Recurrent Trial in Houston (Methotrexate, Etoposide, Ommaya Reservoir)

Recruiting
  • Brain Tumor Recurrent
  • Houston, Texas
    UTHealth & Children's Memorial Hermann Hospital
Aug 17, 2022

Hematological Malignancy Trial in Ningbo (Etoposide, Cytarabine, PEG-rhG-CSF)

Recruiting
  • Hematological Malignancy
  • Etoposide
  • +2 more
  • Ningbo, Zhejiang, China
    The Affiliated People's Hospital of Ningbo University.
Aug 18, 2022

Small Cell Neuroendocrine Carcinoma of Bladder, Bladder Cancer, Urothelial Carcinoma Bladder Trial in Washington, Baltimore

Recruiting
  • Small Cell Neuroendocrine Carcinoma of Bladder
  • +2 more
  • Washington, District of Columbia
  • +1 more
Jun 27, 2022

Extensive-stage Small-cell Lung Cancer Trial in Shanghai (ZKAB001, Placebo, Carboplatin)

Recruiting
  • Extensive-stage Small-cell Lung Cancer
  • ZKAB001
  • +3 more
  • Shanghai, Shanghai, China
    Shanghai Chest Hospital
Sep 8, 2021

DLBCL (DLBCL) Trial (Glofitamab, Obinutuzumab, Tocilizumab)

Not yet recruiting
  • Diffuse Large B-Cell Lymphoma (DLBCL)
  • (no location specified)
Jul 31, 2022

Extensive Stage Small Cell Lung Cancer Trial (Tarlatamab, Carboplatin, Etoposide)

Not yet recruiting
  • Extensive Stage Small Cell Lung Cancer
  • (no location specified)
Aug 19, 2022

Leukemia, MDS Trial (drug, procedure, radiation)

Active, not recruiting
  • Leukemia
  • Myelodysplastic Syndromes
  • (no location specified)
Feb 17, 2022

Lymphoma Trial in Duarte (drug, other, procedure)

Active, not recruiting
  • Lymphoma
  • Duarte, California
    City of Hope Medical Center
Feb 17, 2022

Lymphoma Trial (biological, drug, procedure, radiation)

Completed
  • Lymphoma
  • filgrastim
  • +4 more
  • (no location specified)
Jun 16, 2021

Extensive-stage Small-cell Lung Cancer Trial in Hangzhou (QL1706, Carboplatin, Etoposide)

Recruiting
  • Extensive-stage Small-cell Lung Cancer
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital
Jul 13, 2022

Extensive Stage Small Cell Lung Cancer Trial in France ([177Lu]Lu-DOTA-TATE, Tislelizumab, [68Ga]Ga-DOTA-TATE)

Recruiting
  • Extensive Stage Small Cell Lung Cancer
  • Lille, France
  • +3 more
Aug 9, 2022

Non-Hodgkin's Lymphoma Trial in Philadelphia (drug, procedure, genetic)

Active, not recruiting
  • Non-Hodgkin's Lymphoma
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Jun 3, 2021

Anaplastic Oligoastrocytoma, Anaplastic Oligodendroglioma, Mixed Glioma Trial in Minneapolis, Portland (Carboplatin, Etoposide,

Completed
  • Anaplastic Oligoastrocytoma
  • +3 more
  • Minneapolis, Minnesota
  • +1 more
Mar 11, 2022

Treatment Refusal Trial in Guangzhou (Gemcitabine, etoposide, Pegaspargase)

Recruiting
  • Treatment Refusal
  • Guangzhou, Please Select, China
    Sun Yat-sen University Cancer Center
Dec 16, 2020

Lymphoblastic Leukemia, Lymphoblastic Lymphoma Trial in United States (Everolimus, Nelarabine, Cyclophosphamide)

Recruiting
  • Lymphoblastic Leukemia
  • Lymphoblastic Lymphoma
  • Atlanta, Georgia
  • +3 more
Jul 15, 2021

Leukemia Trial in Duarte (drug, procedure, radiation)

Active, not recruiting
  • Leukemia
  • Duarte, California
    City of Hope Medical Center
Mar 17, 2022

Lymphoma, Multiple Myeloma Trial in China (Etoposide, Cytarabine, PEG-rhG-CSF)

Recruiting
  • Lymphoma
  • Multiple Myeloma
  • Etoposide
  • +2 more
  • Hangzhou, Zhejiang, China
  • +6 more
Sep 7, 2022

Extensive Stage Lung Small Cell Carcinoma Trial in Duarte (Atezolizumab, Carboplatin, Etoposide)

Recruiting
  • Extensive Stage Lung Small Cell Carcinoma
  • Duarte, California
    City of Hope Medical Center
Mar 9, 2022

Small Cell Lung Cancer Trial in Worldwide (Venetoclax, Atezolizumab, Carboplatin)

Terminated
  • Small Cell Lung Cancer
  • Atlanta, Georgia
  • +4 more
Oct 8, 2021

Extranodal NK/T-cell Lymphoma Trial in Beijing (Gemcitabine, Pegaspargase, Etoposide)

Recruiting
  • Extranodal NK/T-cell Lymphoma
  • Beijing, China
    Beijing Tongren Hospital
Jun 2, 2021

Small-cell Lung Cancer Trial (camrelizumab, Apatinib Mesylate, Carboplatin)

Not yet recruiting
  • Small-cell Lung Cancer
  • (no location specified)
Dec 23, 2020